inclusion criteria: 1. provide written informed consent. 2. male or female subjects with a minimum age of 18 years at visit 1. 3. subjects with a stable kidney transplant taking tac and a confirmed diagnosis of sars-cov-2 by nuclear acid testing, with mild-to-moderate symptoms. 4. patients with mild-to-moderate disease symptoms in which mild disease is defined by non-hospitalized patients without oxygen need and moderate disease symptoms are defined by hospitalization to a nursing ward with the need of oxygen therapy. 5. women of childbearing potential must have a negative pregnancy test at baseline. two effective forms of contraception must be used simultaneously unless abstinence is the chosen method. subjects must use effective contraception during the study.

inclusion criteria: 1. provide written informed consent. 2. male or female subjects with a minimum age of 18 years at visit 1. 3. subjects with a stable kidney transplant taking tac and a confirmed diagnosis of sars-cov-2 by nuclear acid testing, with mild-to-moderate symptoms. 4. patients with mild-to-moderate disease symptoms in which mild disease is defined by non-hospitalized patients without oxygen need and moderate disease symptoms are defined by hospitalization to a nursing ward with the need of oxygen therapy. 5. women of childbearing potential must have a negative pregnancy test at baseline. two effective forms of contraception must be used simultaneously unless abstinence is the chosen method. subjects must use effective contraception during the study.

inclusion criteria: provide written informed consent. male or female subjects with a minimum age of 18 years at visit 1. subjects with a stable kidney transplant taking tac and a confirmed diagnosis of sars-cov-2 by nuclear acid testing, with mild-to-moderate symptoms. patients with mild-to-moderate disease symptoms in which mild disease is defined by non-hospitalized patients without oxygen need and moderate disease symptoms are defined by hospitalization to a nursing ward with the need of oxygen therapy. women of childbearing potential must have a negative pregnancy test at baseline. two effective forms of contraception must be used simultaneously unless abstinence is the chosen method. subjects must use effective contraception during the study.

inclusion criteria: provide written informed consent. male or female subjects with a minimum age of 18 years at visit 1. subjects with a stable kidney transplant taking tac and a confirmed diagnosis of sars-cov-2 by nuclear acid testing, with mild-to-moderate symptoms. patients with mild-to-moderate disease symptoms in which mild disease is defined by non-hospitalized patients without oxygen need and moderate disease symptoms are defined by hospitalization to a nursing ward with the need of oxygen therapy. women of childbearing potential must have a negative pregnancy test at baseline. two effective forms of contraception must be used simultaneously unless abstinence is the chosen method. subjects must use effective contraception during the study.

inclusion criteria: 1. provide written informed consent. 2. male or female subjects with a minimum age of 18 years at visit 1. 3. subjects with a stable kidney transplant taking tac and a confirmed diagnosis of sars-cov-2 by nuclear acid testing, with mild-to-moderate symptoms. 4. patients with mild-to-moderate disease symptoms in which mild disease is defined by non-hospitalized patients without oxygen need and moderate disease symptoms are defined by hospitalization to a nursing ward with the need of oxygen therapy. 5. women of childbearing potential must have a negative pregnancy test at baseline. two effective forms of contraception must be used simultaneously unless abstinence is the chosen method. subjects must use effective contraception during the study.

inclusion criteria: 1. provide written informed consent. 2. male or female subjects with a minimum age of 18 years at visit 1. 3. subjects with a stable kidney transplant taking tac and a confirmed diagnosis of sars-cov-2 by nuclear acid testing, with mild-to-moderate symptoms. 4. patients with mild-to-moderate disease symptoms in which mild disease is defined by non-hospitalized patients without oxygen need and moderate disease symptoms are defined by hospitalization to a nursing ward with the need of oxygen therapy. 5. women of childbearing potential must have a negative pregnancy test at baseline. two effective forms of contraception must be used simultaneously unless abstinence is the chosen method. subjects must use effective contraception during the study.